Zurich Cantonal Bank
BNTX icon

Zurich Cantonal Bank’s BioNTech BNTX Stock Holding History

Zurich Cantonal Bank’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.29M Buy
35,373
+10,529
+42% +$991K 0.01% 876
2026
Q1 		$2.21M Buy
24,844
+17,775
+251% +$1.83M ﹤0.01% 994
2025
Q4 		$673K Sell
7,069
-108
-2% -$10.9K ﹤0.01% 1590
2025
Q3 		$708K Buy
7,177
+69
+1% +$7.38K ﹤0.01% 1512
2025
Q2 		$757K Sell
7,108
-171
-2% -$17.3K ﹤0.01% 1401
2025
Q1 		$663K Buy
7,279
+58
+0.8% +$6.49K ﹤0.01% 1417
2024
Q4 		$823K Buy
7,221
+24
+0.3% +$2.74K ﹤0.01% 1307
2024
Q3 		$855K Sell
7,197
-71
-1% -$6.53K ﹤0.01% 1212
2024
Q2 		$584K Buy
7,268
+115
+2% +$10.5K ﹤0.01% 1382
2024
Q1 		$660K Buy
7,153
+121
+2% +$11.6K ﹤0.01% 1301
2023
Q4 		$742K Buy
7,032
+26
+0.4% +$2.62K ﹤0.01% 1238
2023
Q3 		$761K Sell
7,006
-228
-3% -$25.2K ﹤0.01% 1129
2023
Q2 		$781K Sell
7,234
-3,985
-36% -$448K ﹤0.01% 1075
2023
Q1 		$1.4M Sell
11,219
-2,384
-18% -$327K 0.01% 778
2022
Q4 		$2.04M Sell
13,603
-1,965
-13% -$302K 0.01% 665
2022
Q3 		$2.1M Sell
15,568
-6,386
-29% -$976K 0.01% 655
2022
Q2 		$3.27M Sell
21,954
-12,092
-36% -$1.85M 0.02% 571
2022
Q1 		$5.81M Buy
34,046
+5,714
+20% +$960K 0.03% 477
2021
Q4 		$7.28M Buy
28,332
+16,020
+130% +$4.39M 0.04% 421
2021
Q3 		$3.36M Sell
12,312
-1,843
-13% -$586K 0.02% 620
2021
Q2 		$3.18M Sell
14,155
-9,963
-41% -$1.88M 0.02% 609
2021
Q1 		$2.63M Buy
24,118
+222
+0.9% +$23.6K 0.02% 634
2020
Q4 		$1.95M Buy
23,896
+1,501
+7% +$147K 0.01% 745
2020
Q3 		$1.55M Sell
22,395
-20
-0.1% -$1.44K 0.01% 749
2020
Q2 		$1.5M Buy
+22,415
New +$1.12M 0.01% 712

Other funds holding BNTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
GP
GSK plc London $602M AUM

Zurich Cantonal Bank's BNTX Position: Q2 2026 in Review

Zurich Cantonal Bank increased its BioNTech (BNTX) stake by 42% in Q2 2026, buying an estimated $991K and bringing the position to 35,373 shares worth $3.29M. The position accounts for 0.01% of the portfolio, ranked #876.

Zurich Cantonal Bank first reported a position in BNTX in Q2 2020 and has held it in 25 quarters since. The position peaked at $7.28M in Q4 2021. 282 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

  • Zurich Cantonal Bank held 35,373 shares of BioNTech worth $3.29M as of Q2 2026.
  • Zurich Cantonal Bank bought 10,529 BioNTech shares in Q2 2026, an estimated $991K.
  • BioNTech made up 0.01% of Zurich Cantonal Bank's portfolio in Q2 2026, its #876 holding.
  • Zurich Cantonal Bank first reported a position in BioNTech in Q2 2020 and has held it in 25 quarters since.
  • Zurich Cantonal Bank's BioNTech position peaked at $7.28M in Q4 2021.
  • 282 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on Zurich Cantonal Bank's 13F filing for Q2 2026, filed 12 Aug 2026.